Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine

Overview of attention for article published in Cancer Immunology Research, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 3 news outlets

twitter: 11 X users

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 16 X posts from 11 X users, with an upper bound of 30,176 followers.

RRIDs were included in the Cancer Immunology Research paper "Identification of Immunogenic MHC Class II Human H…" (https://t.co/CCy7tEJ90P). RRIDs like this improve reproducibility in scientific research. #ReproducibleResearch #accelerateopenscience

RT @CIR_AACR: Interested in the #AACR22 #CancerVaccine session? Check out study ID'ing immunogenic, promiscuous MHCII HER3 peptides that in…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 12 additional X posts.